MORF - Morphic Holding, Inc.
IEX Last Trade
56.985
56.985 100.000%
Share volume: 0
Last Updated: Fri 16 Aug 2024 11:42:10 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-04 | 2022-08-03 | 2022-11-02 | 2023-02-23 | 2023-04-25 | 2023-08-03 | 2023-11-03 | 2024-02-22 | |
| Assets | |||||||||
| Total Assets | 397.073 M | 413.875 M | 389.181 M | 368.589 M | 441.947 M | 748.720 M | 743.602 M | 722.514 M | |
| Current Assets | 389.494 M | 406.619 M | 382.410 M | 362.182 M | 435.745 M | 742.621 M | 738.097 M | 716.928 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 6.803 M | 8.023 M | 9.988 M | 13.479 M | 13.960 M | 11.265 M | 13.030 M | 12.579 M | |
| Short Term Investments | 6.803 M | 8.023 M | 9.988 M | 13.479 M | 13.960 M | 11.265 M | 13.030 M | 12.579 M | |
| Total Receivables | 2.039 M | 1.036 M | 662.000 K | 455.000 K | 506.000 K | 0.000 | 0.000 | 0.000 | |
| Current Cash | 380.652 M | 397.560 M | 371.760 M | 348.248 M | 421.279 M | 731.356 M | 725.067 M | 704.349 M | |
| Total Non-current Assets | 7.579 M | 7.256 M | 6.771 M | 6.407 M | 6.202 M | 6.099 M | 5.505 M | 5.586 M | |
| Property Plant Equipment | 2.368 M | 2.372 M | 2.170 M | 2.119 M | 2.239 M | 2.507 M | 2.280 M | 2.767 M | |
| Other Assets | 4.651 M | 4.324 M | 4.041 M | 3.728 M | 3.403 M | 3.032 M | 2.665 M | 2.259 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 397.073 M | 413.875 M | 389.181 M | 368.589 M | 441.947 M | 748.720 M | 743.602 M | 722.514 M | |
| Total liabilities | 83.705 M | 25.885 M | 24.120 M | 19.470 M | 15.432 M | 19.359 M | 20.434 M | 25.492 M | |
| Total current liabilities | 43.792 M | 19.684 M | 18.586 M | 17.126 M | 13.481 M | 17.809 M | 19.298 M | 24.776 M | |
| Accounts Payable | 3.496 M | 3.885 M | 4.367 M | 3.475 M | 5.482 M | 3.661 M | 5.268 M | 7.698 M | |
| Other liabilities | 36.435 M | 3.091 M | 2.804 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 3.478 M | 3.110 M | 2.730 M | 2.344 M | 1.951 M | 1.550 M | 1.136 M | 716.000 K | |
| Other liabilities | 36.435 M | 3.091 M | 2.804 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 313.368 M | 387.990 M | 365.061 M | 349.119 M | 426.515 M | 729.361 M | 723.168 M | 697.022 M | |
| Common stock | 37.133 M | 38.245 M | 38.491 M | 38.581 M | 40.112 M | 42.373 M | 49.549 M | 37.527 M | |
| Retained earnings | -269.538 M | -242.697 M | -272.718 M | -297.095 M | -333.230 M | -372.243 M | -408.455 M | -449.190 M |